Bioinformatics expert to design antibody-antigen interface to predict peptide sequences

Dmitri Klimov, Professor, Bioinformatics and Computational Biology, is creating a computational platform for designing an antibody-antigen interface based on DNA origami. DNA origami is a nanoscale assembly of DNA strands with designed two- or three-dimensional shapes.

Klimov's goal is to predict de novo peptide sequences, which bind with high affinity to tetanus toxin. The newly developed algorithms will allow researchers to target structured or unstructured antigen regions and to optimize the placement of designed peptides on the surface of DNA origami.

Klimov and his collaborators will conduct the proposed simulations for this project at Mason. In all, Klimov received $195,414 for this project, which is funded by Parabon Nanolabs, a Reston-based nanotechnology company, with the primary sponsor being the U.S. Army.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of AZoLifeSciences.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
DNA Origami Revolutionizes Cancer Immunotherapy: The DoriVac Breakthrough